2.41 USD
↗ 0.13 (5.70%)AT CLOSE (03:59 PM EST)
enGene Therapeutics Inc. Common Stock (ENGN) is currently trading at $2.41. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 13, 2026.